6 , 25 , 26 In contrast, CSF NfL and glial biomarkers CSF YKL40, GFAP, and sTREM2 (the latter approaching significance) change through aging in both Aβ‐positive and ‐negative individuals.
← all excerpts
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
1
—
—